It’s been a wild ride for Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Charts, News, Analysts, Financials TSX:MDP) over the past couple of months, as the stock has more than doubled since June. But the fun ain’t over yet, according to Raymond James analyst Rahul Sarugaser, who in a Thursday report kept an “Outperform” rating on […]
Leede Jones Gable analyst Douglas W. Loe reiterated a “Speculative Buy” rating on drug developer ProMIS Neurosciences (ProMIS Neurosciences Stock Quote, Charts, News, Analysts, Financials TSX:PMN) in a Monday report. Loe gave a positive review of recent clinical results that relate to ProMIS’ clinical program in treating neurodegenerative diseases such as Alzheimer’s. ProMIS Neurosciences more […]
Share
Tweet
Share
